Home  About us  Contact
 

Platelet Production (platelet + production)

Distribution by Scientific Domains
Medical Sciences100%

Selected Abstracts

Metformin decreases platelet superoxide anion production in diabetic patients

DIABETES/METABOLISM: RESEARCH AND REVIEWS, Issue 2 2002
P. Gargiulo
Abstract Background Patients with type 2 diabetes mellitus are usually treated with oral antidiabetic agents but it is still not known whether these drugs have antioxidant effects in humans. Methods We studied 60 patients with type 2 diabetes mellitus, divided into three groups on the basis of hypoglycaemic treatment (Group A: metformin, Group B: glibenclamide, Group C: diet). All patients were followed for at least 1 year. The three subgroups had similar clinical characteristics. Twenty healthy subjects, of comparable sex and age, were enrolled as controls. In each subject, platelet production of superoxide anion (O2,) elicited by collagen, was determined by lucigenin assay. Results Patients with diabetes had higher platelet O2, production than controls; no correlation was observed between blood glucose and platelet O2, production. Group A patients had platelet O2, production similar to that of healthy subjects but lower than Group B and Group C patients. Conclusion The present findings suggest an in vivo antioxidant activity of metformin and warrant prospective studies to further explore this hypothesis. Copyright © 2002 John Wiley & Sons, Ltd. [source]

Epidemiology and pathophysiology of immune thrombocytopenic purpura

EUROPEAN JOURNAL OF HAEMATOLOGY, Issue 2008
Terry Gernsheimer
Abstract Immune thrombocytopenic purpura (ITP) is characterized by the presence of antiplatelet antibodies and immune platelet destruction. The disorder has been described as having a predilection for young women over men. Bone marrow megakaryocytes appear morphologically and quantitatively normal, and early platelet kinetic studies were consistent with reduced platelet survival as the primary abnormality in ITP. During the last 10,20 yr, understanding of the kinetics of this disorder has evolved with evidence that platelet survival is not as abbreviated as previously thought. Thrombopoietin levels are only minimally elevated, if at all, suggesting marrow stimulation and platelet production may not be maximized. Megakaryocyte physiology appears to be altered in ITP, also suggestive of diminished platelet production. It appears both platelet survival and production are impaired in ITP. The epidemiology of ITP is reviewed here and the pathophysiology of ITP is reconsidered. [source]

Estimating platelet production in patients with HIV-related thrombocytopenia using the immature platelet fraction,,

AMERICAN JOURNAL OF HEMATOLOGY, Issue 12 2009
Brian Garibaldi
No abstract is available for this article. [source]

Mean platelet volume in neonatal respiratory distress syndrome

PEDIATRICS INTERNATIONAL, Issue 2 2009
Fuat Emre Canpolat
Abstract The aim of this study was to investigate the differences in mean platelet volume (MPV) between neonates with and without neonatal respiratory distress syndrome (RDS). Eighty-three premature infants who were admitted to the neonatal intensive care unit were included in the study. Forty-four of these infants were diagnosed as having RDS and the other 39 infants were non-RDS patients. Infants born to mothers with pre-eclampsia, or a drug history that had negative effects on platelet count, perinatal hypoxia, sepsis and necrotizing enterocolitis were excluded. Blood collection was done on the first and third days of life. There were no demographic, gestational or platelet count differences between groups, but MPV was higher in RDS patients and this difference was statistically significant (P= 0.011). High platelet volumes in RDS patients is probably related to young platelet production and may be a result of increased platelet consumption in pulmonary damage due to RDS. [source]